Results 151 to 160 of about 1,730,491 (239)

Argyrin B exhibits potent therapeutic efficacy in a Clostridioides difficile-infection mouse model while preserving microbiota functionality. [PDF]

NPJ Antimicrob Resist
Rasheed S, Ehrhardt K, Mohamed Mostafa Abdrabou A, Mellmann A, Lechleiter A, Pogorevc D, Junker S, von Müller L, Vital M, Herrmann J, A Grassl G, Bischoff M, Müller R.   +12 more
europepmc   +1 more source

Peritoneal dialysis associated peritonitis and Clostridioides difficile infection: Association or different entities? [PDF]

CEN Case Rep
Meléndez-Flores JD, Mendoza-Cardiel AA, Arreola-Sánchez AI, Alcalá-González JI.   +3 more
europepmc   +1 more source

Dynamics in Circulating Immune Cell Subsets After Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection. [PDF]

Clin Transl Gastroenterol
Eriksen LL, Støy S, Mejlby Hansen M, Porsborg Gatten E, Erikstrup C, Kelsen J, Mullish BH, Marchesi JR, Thomsen KL, Dahlerup JF, Dahl Baunwall SM, Hvas CL.   +11 more
europepmc   +1 more source

Letter: Dose and Donor Matter-Determining the Optimal Strategy for Faecal Microbiota Transplantation in Clostridioides difficile Infection. [PDF]

Aliment Pharmacol Ther
Bogatic D, Costello SP, Bryant RV.
europepmc   +1 more source

Antibiotic and Nonantibiotic Drugs Associated With Clostridioides difficile Infection Risk: a Pharmacopoeia-Wide Case-Cohort Study. [PDF]

J Infect Dis
Brown KA, Coburn B, Hernandez A, Langford BJ, Leung V, MacFadden D, Rooney AM, Schwartz KL, Daneman N.   +8 more
europepmc   +1 more source

Vancomycin Taper-and-Pulse Therapy for Recurrent Clostridioides difficile Infection in Pediatric Acute Lymphoblastic Leukemia Patients Treated With Blinatumomab and Chemotherapy: A Report of Three Cases. [PDF]

Cureus
Lu H, Xi H.
europepmc   +1 more source

Primary Prophylaxis for Clostridioides difficile Infection in Lung Transplant Recipients: A Retrospective Study. [PDF]

Transpl Infect Dis
Irwin M, Leedy N, Nandavaram S, Soria J, Myint T.   +4 more
europepmc   +1 more source

Efficacy Outcomes of Fecal Microbiota, Live-jslm in Preventing Recurrent Clostridioides difficile Infection from Seven Clinical Studies. [PDF]

Infect Dis Ther
Chopra T, Van Handel D, Baggott B, Orenstein R, Reveles K, Guthmueller B, Srivastava S, Khanna S.   +7 more
europepmc   +1 more source

Clostridioides difficile Infection Among Hospitalized Patients With Cancer.

JAMA Netw Open
Roldan GA, Goble S, Davie T, Fletcher J, Campoverde L, Mendoza MA, Moutsoglou DM.   +6 more
europepmc   +1 more source